細胞内標的化スマートナノDDSを用いた効率的かつ安全ながんワクチンの開発
細胞内標的化スマートナノDDSを用いた効率的かつ安全ながんワクチンの開発
批准号:
17F17035
负责人:
Quader Sabina
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for JSPS Fellows
财政年份:
2017
资助国家:
日本
项目状态:
已结题
起止时间:
2017-04-26 至 2019-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We synthesized glucose decorated and epirubicin conjugated polymeric micelles that have pH-sensitive release profile. Epirubicin micelles had small size and uniform size distribution. We prepared epirubicin micelle decorated with different amount of glucose ( 0%, 25%, 50%, and 100%). The surface decoration of micelles by glucose molecule significantly affected their endocytosis, and fate in the cytoplasm. Specifically, glucose conjugated micelles are accompanied by exocytosis mechanism in parallel to endocytosis under monolayer cell culture condition with GLUT-1 overexpressed cell. Furthermore, under 3D multicellular tumor spheroid condition, this exocytosis mechanism of glucose micelles helps to drive the glucose micelles to penetrate deeper into tumor spheroid following transcytosis. And we observed, glucose epirubicin micelles having higher penetration than control micelles (that is 0% glucose decorated micelle). We confirmed that the epirubicin micelles with different amount of glucose decoration have long blood circulation property, which is one of the prerequisites for its therapeutic activities. We performed tumor accumulation and antitumor activity in an orthotopic breast cancer model. This tumor model had been selected as a pilot-study due to the fact that MDA-MB-231 cells overexpress GLUT1. We found significant difference between free epirubicin and epirubicin micelle groups. But no difference between the micelle groups was observed. Antitumor activity study against Glioblastoma models is currently undergoing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delivering Melittin using Crosslinked and pH responsive Nanomedicine
使用交联和 pH 响应纳米药物提供蜂毒肽
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka]
通讯作者:
Kazunori Kataoka
Developing Nanomedicine that targets cellular heterogeneity for Complete Glioblastoma Remission
-
批准号:21K12697
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2021
-
负责人:Quader Sabina
-
依托单位:
Exploiting Neomycin-RNA complexation to create PIC micelle based efficient transportation for therapeutic siRNA
-
批准号:16K12904
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2016
-
负责人:Quader Sabina
-
依托单位:
海外基金